US2018221415A1PendingUtilityA1
Scaffold for growing neuronal cells and tissue
Assignee: TECHNION RES & DEV FOUNDATIONPriority: Feb 23, 2012Filed: Nov 29, 2017Published: Aug 9, 2018
Est. expiryFeb 23, 2032(~5.5 yrs left)· nominal 20-yr term from priority
A61L 2300/414A61K 35/30A61L 27/18A61L 27/3886A61L 27/3808A61L 27/383A61K 35/33A61L 27/56A61L 27/54A61L 27/3804A61K 35/44A61L 27/34
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a composition based on poly-l-lactic acid (PLLA) acid polylactic-co-glycolic-acid (PLGA) scaffold on which neuronal tissue can ex-vivo grow. Further, more the invention provides a method for making cellular vasculature networks and a method for treating a neuronal injury in a subject, by implanting the current composition.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a neuronal injury in a subject, comprising the step of implanting an ex-vivo vascularized implant in a site of neuronal injury, said ex-vivo vascularized implant comprises: a porous sponge comprising poly-l-lactic acid (PLLA) and polylactic-co-glycolic-acid (PLGA); olfactory bulb cells attached to the surface of said porous sponge and within said porous sponge; an endogenous nerve growth factor (NGF) de-novo produced by said olfactory bulb cells; and vasculature formed in-vitro within said porous sponge, thereby treating a neuronal injury in a subject.
2 . The method of claim 1 , wherein said olfactory bulb cells express the NGF receptor p75NTR.
3 . The method of claim 1 , wherein said olfactory bulb cells comprise fibroblasts, astrocytes and olfactory ensheathing cells.
4 . The method of claim 1 , wherein said ex-vivo vascularized implant further comprises an endothelial cell, a fibroblast, or both.
5 . The method of claim 1 , wherein said ex-vivo vascularized implant further comprises fibronectin, fibrin, thrombin, or any combination thereof.
6 . The method of claim 1 , wherein said ex-vivo vascularized implant further comprises brain-derived neurotrophic factor (BDNF) de-novo produced by said olfactory bulb cells.
7 . A method for making a neuronal ex-vivo vascularized implant, comprising the step of co-culturing cells on a 3D scaffold in the presence of culture medium, said cells comprises olfactory bulb cells and endothelial cells, said 3D scaffold comprises poly-l-lactic acid (PLLA) and polylactic-co-glycolic-acid (PLGA), said neuronal ex-vivo vascularized implant produces nerve growth factor (NGF), thereby making a neuronal ex-vivo vascularized implant.
8 . The method of claim 7 , wherein said ex-vivo vascularized implant expresses the NGF receptor p75NTR.
9 . The method of claim 7 , wherein said olfactory bulb cells comprise fibroblasts, astrocytes and olfactory ensheathing cells.
10 . The method of claim 7 , wherein said 3D scaffold further comprises fibronectin, fibrin, thrombin, or any combination thereof.
11 . The method of claim 7 . wherein said ex-vivo vascularized implant further comprises brain-derived neurotrophic factor (BDNF) de-novo produced by said olfactory bulb cells.Join the waitlist — get patent alerts
Track US2018221415A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.